|
|
||||||||||
|
J Am Coll Cardiol, 2001; 37:19-25 © 2001 by the American College of Cardiology Foundation |



* Veterans Affairs Medical Center and the University of Cincinnati, Cincinnati, Ohio, USA
Veterans Affairs Medical Center, Houston, Texas, USA
Department of Veterans Affairs Cooperative Studies Program Coordinating Center, Palo Alto, California, USA
Veterans Affairs Medical Center, Seattle, Washington, USA
|| State University of New York Health Science Center, Syracuse, New York, USA
** Hartford Hospital, Hartford, Connecticut, USA
Manuscript received January 19, 2000; revised manuscript received July 24, 2000, accepted September 13, 2000.
Reprint requests and correspondence: Dr. Laura F. Wexler, Cardiology Section, Department of Veterans Affairs Medical Center, 3200 Vine Street, Cincinnati, Ohio 45220
Wexlerl{at}ucmail.uc.edu
OBJECTIVES
We wished to determine the effect of post-infarct management strategy on event rates (death or recurrent nonfatal myocardial infarction [MI]) in patients who evolved nonQ-wave MI (NQMI) following thrombolytic therapy.
BACKGROUND
Patients who evolve NQMI following thrombolytic therapy are often considered to be at high risk and are frequently managed with routine early invasive testing despite a lack of data supporting improved outcome.
METHODS
The Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) study included 115 patients who evolved NQMI following thrombolytic therapy. We compared the event rates in patients randomized to routine early coronary angiography with those in patients randomized to a conservative strategy of noninvasive functional assessment, with angiography reserved for patients with spontaneous or induced ischemia.
RESULTS
During an average follow-up of 23 months, 19 of 58 patients (33%) randomized to the invasive management strategy died or suffered recurrent nonfatal MI, compared with 11 of 57 patients (19%) randomized to the conservative strategy (p = 0.152). Equivalent numbers of patients were subjected to revascularization (percutaneous transluminal coronary angioplasty or coronary artery bypass graft). There were more deaths in the invasive management group than in the conservative management group (11 vs. 2). Excess deaths could not be attributed to periprocedural mortality.
CONCLUSIONS
Overall event rates (death or recurrent nonfatal MI) are comparable with conservative and invasive strategies in patients who evolve NQMI following thrombolytic therapy. Mortality rate in patients managed conservatively is low (3.5%), and routine invasive management may be associated with an increased risk of death.
| ||||||||||||||||||||
This article has been cited by other articles:
![]() |
G. A. Lin, R. A. Dudley, and R. F. Redberg Cardiologists' Use of Percutaneous Coronary Interventions for Stable Coronary Artery Disease Arch Intern Med, August 13, 2007; 167(15): 1604 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, M. Pu, D. Rodriguez, D. Underwood, B. P. Griffin, V. Kalahasti, J. D. Thomas, and R. C. Brunken Ischemic and viable myocardium in patients with Non-Q-Wave or Q-Wave myocardial infarction and left ventricular dysfunction: A clinical study using positron emission tomography, echocardiography, and electrocardiography J. Am. Coll. Cardiol., February 18, 2004; 43(4): 592 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
PCI Not Mandatory if Fibrinolysis Is Successful Journal Watch Emergency Medicine, April 2, 2001; 2001(402): 5 - 5. [Full Text] |
||||
![]() |
Conservative Management for Post-Thrombolytic Non-Q-Wave MI Journal Watch Cardiology, March 16, 2001; 2001(316): 7 - 7. [Full Text] |
||||
![]() |
Is Non-Q-Wave MI After Thrombolytic Therapy an Indication for Angiography? Journal Watch (General), February 9, 2001; 2001(209): 7 - 7. [Full Text] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |